Resultado de búsqueda
Hace 5 días · May 16 (Reuters) - Roche (ROG.S) shares gained as much as 4.7% on Thursday after an early-stage trial showed that a newly-acquired obesity drug candidate led to significant weight loss, a key...
Hace 5 días · Roche’s once-weekly CT-388 injection led to “clinically meaningful and statistically significant” results for patients with obesity compared with a placebo, resulting in weight loss of 18.8 per...
Hace 5 días · (Reuters) -Roche shares gained as much as 4.7% on Thursday after an early-stage trial showed that a newly-acquired obesity drug candidate led to significant weight loss, a key step in Swiss...
Hace 5 días · L ONDON — Roche on Thursday said its recently acquired experimental obesity medication helped people lose a significant amount of weight in an early trial, sending its shares up in early trading.
Hace 5 días · An experimental Roche drug helped people with obesity lose an average of nearly 19% of their body weight over six months, after adjusting for placebo, in an early-stage trial, the company said Thursday.
Hace 5 días · Roche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial, giving the company a boost in its bid to catch up to Novo Nordisk and Eli Lilly in a class of...
Hace 5 días · The obesity drug candidate Roche bought as part of its Carmot deal--known as CT-388--showed positive results in a phase 1 study, by leading to significant weight loss in healthy adults with...
